Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by...

Area of Science:

• Neuroimmunology
• Infectious Disease Immunology
• Autoimmune Disorders

Background:

• Epstein-Barr virus (EBV) is a known environmental factor linked to neuromyelitis optica spectrum disorder (NMOSD).
• Studies in multiple sclerosis (MS) suggest cross-reactivity between Mycobacterium avium subsp. paratuberculosis (MAP) peptides and Epstein-Barr virus (EBV)/human epitopes (MBP, IRF5).

Purpose of the Study:

• To investigate if serological reactivity to MAP and myelin basic protein (MBP) peptides follows a distinct pattern in NMOSD compared to MS and healthy controls.
• To assess the role of EBV, MAP, and MBP antibodies in NMOSD pathogenesis.

Main Methods:

• Analysis of serum antibody levels against MAP, MBP, and EBV in 34 NMOSD patients and healthy controls.
• Comparison of serological findings between NMOSD patients, previously studied MS cohorts, and healthy controls.

Main Results:

• NMOSD patients exhibited significantly higher levels of antibodies against MAP (44% vs. 5%, p<0.0002) and MBP (50% vs. 2%, p<0.0001) compared to healthy controls.
• In contrast to MS findings, antibody responsiveness to EBV was comparable between NMOSD patients and healthy controls.
• These results suggest a specific immune response pattern in NMOSD involving MAP and MBP.

Conclusions:

• Seroreactivity to MAP and MBP, but not EBV, appears to be a distinguishing feature in NMOSD.
• The findings support the hypothesis of molecular mimicry involving MAP and MBP in NMOSD pathogenesis.
• Further research is warranted to elucidate the precise role of these microbial antigens in NMOSD development.